Abnormal Expression of E-Cadherin in Gastric Adenocarcinoma, and Its Correlation With Tumor Histopathology and Helicobacter Pylori Infection

被引:19
作者
Anbiaee, Robab [1 ]
Sheibani, Khosrow Mojir [2 ]
Torbati, Peyman [3 ]
Jaam, Hanieh [4 ]
机构
[1] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Dept Oncol, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Dept Radiotherapy & Oncol, Imam Hossein Hosp, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Labafi Nejad Hosp, Dept Pathol, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Shohada E Tajrish Hosp, Dept Pathol, Tehran, Iran
关键词
Stomach Neoplasms; Cadherin; Helicobacter Pylori; PROMOTER HYPERMETHYLATION; PATIENT SURVIVAL; CATENIN COMPLEX; DOWN-REGULATION; CANCER; GENE; CARCINOMA;
D O I
10.5812/ircmj.4032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Gastric cancer is one of the leading cancers in the world especially in Iran. There are many genomic and molecular factors that cause gastric cancer to occur, and also there are many markers that associate with tumor invasiveness. E-cadherin is a tumor suppressor gene which produces E-cadherin transmembrane protein, a molecule which plays an important role in adhesion and differentiation of epithelial cells. Objectives: In this study, we evaluated the prevalence of abnormal E-cadherin expression in Iranian patients with gastric adenocarcinoma, and tried to find its correlation with H. pylon infection and tumor histopathology. Materials and Methods: A historical cohort survey was performed on tissue samples obtained from 95 total or partial gastrectomy with gastric adenocarcinoma. The immunohistochemistry and Giemsa staining were used to assess E-cadherin expression, and H- pylon infection respectively. The association between abnormal E-cadherin expression and tumor histopathology characteristics include depth of tumor invasion, tumor differentiation, tumor phenotype, tumor type, tumor size, neurovascular invasion of tumor, and regional lymph node involvement and H- pylon infection and patient's age and sex, were evaluated in all patients. Results: Abnormal E-cadherin expression was noted in 38% of patients, and 59% of patients were infected with H-pylon. A significant correlation was seen between abnormal E-cadherin expression, and tumor grade and regional lymph node involvement. We could not find any significant association between abnormal E-cadherin expression and H- pylon infection, patient's age and sex, tumor phenotype, tumor type, depth of tumor invasion, tumor size, and neurovascular invasion of tumor. Conclusions: Abnormal E-cadherin expression is a common phenomenon in gastric adenocarcinoma. The study showed a significant correlation between abnormal E-cadherin expression and tumor grade and regional lymph node involvement; so, abnormal E-cadherin expression maybe used as a predictive factor for tumor invasiveness in gastric adenocarcinoma.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 12 条
  • [1] [Anonymous], 2003, J CLIN PATHOL, V56, P849
  • [2] Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer
    Chan, AOO
    Lam, SK
    Wong, BCY
    Wong, WM
    Yuen, MF
    Yeung, YH
    Hui, WM
    Rashid, A
    Kwong, YL
    [J]. GUT, 2003, 52 (04) : 502 - 506
  • [3] Charalabopoulos K, 2003, EXP ONCOL, V25, P270
  • [4] Devita JR, 2012, CANC PRINCIPLES PRAC
  • [5] Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer
    Graziano, F
    Arduini, F
    Ruzzo, A
    Bearzi, I
    Humar, B
    More, H
    Silva, R
    Muretto, P
    Guilford, P
    Testa, E
    Mari, D
    Magnani, M
    Cascinu, S
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (08) : 2784 - 2789
  • [6] Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer:: implications for treatment with demethylating drugs
    Graziano, F
    Arduini, F
    Ruzzo, A
    Mandolesi, A
    Bearzi, I
    Silva, R
    Muretto, P
    Testa, E
    Mari, D
    Magnani, M
    Scartozzi', M
    Cascinu, S
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (03) : 489 - 492
  • [7] Guzmán P, 2006, REV MED CHILE, V134, P1002
  • [8] Halperin EC, 2008, PRINCIPLE PRACTICE R
  • [9] Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
    Jawhari, A
    Jordan, S
    Poole, S
    Browne, P
    Pignatelli, M
    Farthing, MJG
    [J]. GASTROENTEROLOGY, 1997, 112 (01) : 46 - 54
  • [10] Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas:: Correlation with clinicopathologic characteristics and Helicobacter pylori infection
    Shun, CT
    Wu, MS
    Lin, MT
    Chang, MC
    Lin, JT
    Chuang, SM
    [J]. ONCOLOGY, 2001, 60 (04) : 339 - 345